FR2397834A1 - Compositions radiographiques - Google Patents

Compositions radiographiques

Info

Publication number
FR2397834A1
FR2397834A1 FR7821046A FR7821046A FR2397834A1 FR 2397834 A1 FR2397834 A1 FR 2397834A1 FR 7821046 A FR7821046 A FR 7821046A FR 7821046 A FR7821046 A FR 7821046A FR 2397834 A1 FR2397834 A1 FR 2397834A1
Authority
FR
France
Prior art keywords
group
acid
carbon atoms
radiographic
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7821046A
Other languages
English (en)
Inventor
Harry S Winchell
Tz-Hong Lin
Charles A Panneciere
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2397834A1 publication Critical patent/FR2397834A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/10—Polyhydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/10—Polyhydroxy carboxylic acids
    • C07C59/105—Polyhydroxy carboxylic acids having five or more carbon atoms, e.g. aldonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/255—Tartaric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265—Citric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/62—Three oxygen atoms, e.g. ascorbic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des complexes hydratés. Il s'agit d'un complexe hydraté soluble dans l'eau, non toxique, d'un métal choisi dans le groupe constitué par l'hafnium et le tantale, et d'un agent complexant acide organique choisi dans le groupe suivant : a. Les acides organiques ayant entre 2 et 7 atomes de carbone et au moins un groupe hydroxyle ; b. Les acides aminés contenant de 2 à 8 atomes de carbone; et c. Un acide phosphonique choisi parmi le groupe constitué par l'acide éthylènediaminetétraméthylènephosphonique, l'acide diéthylènepentaméthylènephosphonique, et les acides disphophoniques représentés par la formule :
FR7821046A 1977-07-18 1978-07-13 Compositions radiographiques Withdrawn FR2397834A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/816,618 US4176173A (en) 1977-07-18 1977-07-18 Radiographic compositions

Publications (1)

Publication Number Publication Date
FR2397834A1 true FR2397834A1 (fr) 1979-02-16

Family

ID=25221144

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7821046A Withdrawn FR2397834A1 (fr) 1977-07-18 1978-07-13 Compositions radiographiques

Country Status (5)

Country Link
US (1) US4176173A (fr)
JP (1) JPS5422327A (fr)
DE (1) DE2831524A1 (fr)
FR (1) FR2397834A1 (fr)
GB (1) GB2001969B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3129906C3 (de) * 1981-07-24 1996-12-19 Schering Ag Paramagnetische Komplexsalze, deren Herstellung und Mittel zur Verwendung bei der NMR-Diagnostik
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
US4957939A (en) * 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
US4478816A (en) * 1982-06-07 1984-10-23 Georgetown University Rare earth/chelating agent complex for digital fluoroscopy
NL194579C (nl) * 1983-01-21 2002-08-05 Schering Ag Diagnostisch middel.
US5204085A (en) * 1985-01-08 1993-04-20 Mallinckrodt Medical, Inc. Method for enhancing the safety of metal-ligand chelates as X-ray contrast agents
JPS63251707A (ja) * 1987-04-06 1988-10-19 Uchida Seisakusho:Kk 石油燃焼器具の芯上下装置
JPS63251706A (ja) * 1987-04-06 1988-10-19 Uchida Seisakusho:Kk 石油燃焼器具の芯昇降装置
JPS641220U (fr) * 1987-06-19 1989-01-06
JPS6438462U (fr) * 1987-09-02 1989-03-08
GB9006977D0 (en) * 1990-03-28 1990-05-23 Nycomed As Compositions
IT1246380B (it) * 1990-04-12 1994-11-18 Bracco Spa Sali insolubili di lantanidi per la visualizzazione in risonanza magnetica nucleare del tratto gastro-intestinale
CA2106976A1 (fr) * 1991-03-27 1992-09-28 Torsten Almen Produit de contraste
DE69231966T2 (de) 1991-08-05 2001-11-15 Mallinckrodt Inc Schwermetallcluster zur verwendung als abbildungsmittel
GB2317177A (en) * 1996-09-13 1998-03-18 British Steel Plc Organic phosphonates and metal complexes thereof for use as coating agents and especially for pretreating steel

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2151706B1 (en) * 1971-10-18 1973-05-03 Cegla, Ulrich, Dr med , 600 0 Frank fürt Niederrad Tantalum-contg x-ray contrast agents - in aerosol form for bronchography
US3937800A (en) * 1972-07-17 1976-02-10 Dure Smith Peter Bronchographic x-ray contrast method

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB238543A (en) * 1924-08-13 1926-03-11 Philips Nv Improved process for converting hafnium and zirconium phosphates into other hafnium and zirconium compounds
AT202551B (de) * 1956-06-02 1959-03-10 Kurt Dipl Ing Dr Phil D Peters Verfahren zur Herstellung von Komplexverbindungen
DK100609C (da) * 1958-09-06 1964-12-21 Henkel & Cie Gmbh Fremgangsmåde til ved kompleksdannelse at binde ioner af di- og trivalente metaller i opløsninger.
DE1110822B (de) * 1960-09-12 1961-07-13 Pierre Castel Roentgenkontrastmittel
US3198817A (en) * 1960-11-08 1965-08-03 Dow Chemical Co Insoluble chelates of titanium, zirconium, hafnium and thorium
GB1054265A (fr) * 1962-11-07 1900-01-01
US4020091A (en) * 1965-10-28 1977-04-26 Plains Chemical Development Co. Chelation
SE397473B (sv) * 1974-03-14 1977-11-07 Pharmacia Ab Anvendningen av polymerpartiklar som tillsatsmedel i rontgenkontrastmedel baserade pa bariumsulfat eller liknande
US4029696A (en) * 1976-04-09 1977-06-14 Benckiser-Knapsack Gmbh N-hydroxy alkane amino alkane diphosphonic acids, process of producing same, and compositions for and method of using same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2151706B1 (en) * 1971-10-18 1973-05-03 Cegla, Ulrich, Dr med , 600 0 Frank fürt Niederrad Tantalum-contg x-ray contrast agents - in aerosol form for bronchography
US3937800A (en) * 1972-07-17 1976-02-10 Dure Smith Peter Bronchographic x-ray contrast method

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CA1954 *
CA1965 *
CA1971 *
CA1975 *
CA1977 *

Also Published As

Publication number Publication date
GB2001969B (en) 1982-02-10
GB2001969A (en) 1979-02-14
DE2831524A1 (de) 1979-02-01
US4176173A (en) 1979-11-27
JPS62917B2 (fr) 1987-01-10
JPS5422327A (en) 1979-02-20

Similar Documents

Publication Publication Date Title
FR2397834A1 (fr) Compositions radiographiques
KR870004021A (ko) 포르피린 유도체의 제조방법
EP0322242A3 (fr) Dérivés d'adénosine
CA2056596A1 (fr) Derives de substitution en 2 d'adenosine; compositions pharmaceutiques pour les maladies du systeme circulatoire
FR2437460A1 (fr) Agent hydrofuge et oleofuge ayant une resistance elevee au blanchissage et au nettoyage a sec
CA2015475A1 (fr) Agent pour le traitement de l'osteoarthrite
CA2147883A1 (fr) Derive du cyclohexanol; composition a base de ce derive communiquant une sensation de frais; methode de preparation du derive et produit intermediaire utile a cette fin
RU92016214A (ru) Производные 2-имидазолин-5-онов и 2-имидазолин-5-тионов, способ их получения, фунгицидный состав на их основе и способ обработки культур
ES8301476A1 (es) Procedimiento para la obtencion de derivados del acido 2-(3'-hidroxipirid-2'-il)-2-tiazolin-4-carboxilico
CA2421114A1 (fr) Derives 5-asa ayant une activite anti-inflammatoire et antibiotique, procedes de traitement de maladies a l'aide de ces derniers
RU2000128648A (ru) Комплексные соединения платины, способы их получения и фармацевтическая композиция
FR2382239A1 (fr) Compose drogue-polymere absorbable et procede de preparation
CA2412932A1 (fr) Derives de pleuromutiline presentant une activite antibacterienne
FR2382467A1 (fr) Resine phenolique chelatee et procede de traitement par adsorption
FR2385397A1 (fr) Compositions stables d'un sel alcalin ou alcalino-terreux d'acide 5-methyltetrahydrofolique a usage therapeutique
CA2241092A1 (fr) Derives de 1-methylcarbapenem
FR2358383A1 (fr) Derives de peptides a activite biologique
FR2413086A1 (fr) Compositions fluorochimiques et procede pour inhiber la formation de plaque dentaire
CA2003880A1 (fr) Produit radiopharmaceutique ayant notamment un tropisme cardiaque comportant un complexe nitruro d'un metal de transition, et son procede de preparation
DK171487A (da) Spergualinderivater, fremgangsmaade til deres fremstilling og deres anvendelse som laegemidler
KR960029339A (ko) 디티오세미카르바존 유도체 또는 디아민 디올 시프 염기 유도체의 방사성 구리 착물을 함유하는 저산소중 또는 미토콘드리아 기능 장애용 진단제
TNSN88003A1 (fr) Compositions therapeutiques des nouveaux derives oxy-5 du tetrahydrofurane
KR890005228A (ko) 금속 착물염료 제조시 이온 생산성 중금속 함량을 감소시키는 방법
BR8105437A (pt) Processo para a preparacao de derivados de azolilaquila, composicoes fungicidas, processos para combater fungos e para a preparacao das composicoes
FR2640269A1 (fr) Composes organometalliques, leurs modes de preparation et compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
ST Notification of lapse